Anxiety and stress in children
Childhood emotional disorders form a broad category. For clinically significant anxiety, international guidelines (AACAP 2020, NICE NG134) list cognitive behavioural therapy and, in severe forms, SSRIs. Homeopathic remedies are not part of these documents.
ICD-10 F932 drugs
Also known as: Childhood neurotic reactions
Marketing claims without evidence base
The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.
- DAntibodies to S-100 brain-specific protein (homeopathic)Not recommended · Homeopathic products (local classification)A homeopathic preparation of antibodies to brain-specific protein S-100. It is promoted as a gentle calming remedy for anxiety and stress in children. Convincing benefit for this use has not been shown, and there is no evidence base for it here. What actually helps an anxious child is a steady sleep routine, support from family, and, when symptoms are marked, work with a child psychologist or therapist. Do not use this product in place of treatment with proven benefit, since that can mean missing the care a child needs.
- FHopantenic acid (calcium hopantenate)Not recommended · Nootropics (local classification). Russian and Japanese development.For paediatric neurosis-like and tic disorders, pantogam is prescribed in Russia in 1–3 month courses. AAP and AACAP paediatric anxiety and tic guidelines do not list the drug. First-line international guidance is CBT; SSRIs (sertraline, fluoxetine) in children over 6 are used for confirmed anxiety disorder.
How to read tiers A–F
Evidence tiers belong to the drug-indication pair, not to the drug as a whole: the same substance can be A for one condition and F for another.
- AStrong evidence – first or second line in international guidelines
- BRecommended in selected cases
- CStudy data contradict each other
- DBenefit not proven, no documented harm
- FDocumented harm, or risk without benefit